二膦酸盐作用的细胞学研究进展
出处
《河北医科大学学报》
CAS
2000年第5期317-319,共3页
Journal of Hebei Medical University
参考文献21
-
11，SatoM,GrasserW,EndoN,etal.Bisphosphonatesaction.Alendronatelocalisationinratboneandeffectsonosteoclastultrastructure.JClinInvest,1991,88(6):2095
-
22，MurakamiH,TakahashiN,SasakiT,etal.Apossiblemechanismofthespecificactionofbisphosphonatesonosteoclast:tiludronatepreferentiallyaffectspolarizedosteoclasthavingruffledborders.Bone,1995,17(2):137
-
33，MonkkonenJ,TaskinenM,AuriolaSOK,etal.Growthinhibitionofmacrophige-likeandothercelltypesbyliposome-encapsulated,calcium-boundandfreebisphosphonatesinvitro.JDrugTarget,1994,2(4):299
-
44，RogersMJ,ChiltonKM,CoxonF,etal.Bisphosphonatesinduceapoptosisinmousemacrophage-likecellsbyanitric-oxide-independentmechanism.JBoneMinerRes,1996,11(9):1482
-
55，ShipmanCM,RogersMJ,AppreleyJF,etal.Bisphosphonatesinduceapoptosisinhumanmyelomacells;anovelantitumoractivity.BrJHaematol,1997,98(3):665
-
66，SchmidtA,RutledgeSJ,EndoN,etal.Alendronateinhibitionofproteintyrosinephosphataseactivity.ProcNatlAcadSciUSA,1996,93(7):3068
-
77，RogersMJ,RussellRGG,BlackburnGM,etal.Metabolismofhalogenatedbisphosphonatesbythecellularslimemoulddictyosteliumdiscoideum.BiochemBiophysResCommun,1992,189(1):414
-
88，RogersMJ,WattsDJ,RussellRGG,etal.Inhibitoryeffectsofbisphosphonatesongrowthofamoebaeofthecellularslimemoulddictyosteliumdiscoideum.JBoneMinerRes,1994,9(7):1029
-
99，SahniM,GuentherHL,FleischH,etal.Bisphosphonatesactonratboneresorptionthroughthemediationofosteoblasts.JClinInvest,1993,91(5):2004
-
1010，RogersMJ,XiongX,BrownRJ,etal.Structure-activityrelationshipsofnewheterocycle-containingbisphosphonatesasinhibitorsofboneresorptionandasinhibitorsofgrowthofdictyosteliumdiscoideumamoebae.MolPharmacol,1995,42(2):398
-
1叶文润,邓杰,乐嘉赓.二膦酸盐药物的研究进展及临床应用[J].中国药房,1996,7(3):135-137. 被引量：9
-
2程琼.维生素D抗乳癌作用的研究进展[J].泰山医学院学报,1996,17(1):81-83. 被引量：1
-
3最新药品不良反应警示[J].福建质量管理,2005(6):11-11.
-
4最新药品不良反应警示[J].中国医药指南,2005,3(9):7-7.
-
5史宁.二膦酸盐给药途径依赖性药代动力学模型的确定性及生物利用度的测定[J].国外医学（药学分册）,2002,29(1):60-61.
-
6王文英,徐向荣.绝经后骨质疏松症的药物治疗[J].中国药业,1999,8(4):50-51.
-
7李文倩,郝贵生.多西紫杉醇联合用药治疗晚期非小细胞肺癌30例分析[J].中国医院药学杂志,2006,26(8):991-992. 被引量：5
-
8翟远坤(综述),李志锋(综述),程国政(综述),陈克明(审校).淫羊藿苷抗骨质疏松研究进展[J].中国骨质疏松杂志,2009,15(7):543-545. 被引量：13
-
9刘月芬,尤琳,李恩泽,李成建.阿仑膦酸钠不良反应[J].中国误诊学杂志,2011,11(16):3804-3804. 被引量：2
-
10焦利萍.紫杉醇联合顺铂治疗晚期非小细胞肺癌不良反应的观察和护理[J].中国临床医生杂志,2008,36(6):52-52. 被引量：6
;
